Duavee (conjugated estrogens/bazedoxifene) tablets 0.45/20 mg, packaged in 2 blister cards contai...

FDA Drug Recall #D-1342-2020 — Class III — May 27, 2020

Recall Summary

Recall Number D-1342-2020
Classification Class III — Low risk
Date Initiated May 27, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Pfizer Inc.
Location New York, NY
Product Type Drugs
Quantity 544400 packages

Product Description

Duavee (conjugated estrogens/bazedoxifene) tablets 0.45/20 mg, packaged in 2 blister cards containing 15 tablets each (30 tablets), Rx Only, Distributed by Wyeth Pharmaceuticals LLC A subsidiary of Pfizer In Philadelphia, PA 19101 Made in Ireland, NDC 00008-1123-12

Reason for Recall

Failed Dissolution Specifications

Distribution Pattern

Nationwide within the United States

Lot / Code Information

Lot #: AF7814, 2021 AUG 31; AH6565, 2021 SEP 30, AP5189, 2020 SEP30; CG8921, 2022 FEB 28; CL6603, DH5847, 2022 MAR 31; T17703, T99214 2020 JUN 30, W46878, X07330, 2020 SEP 30; X99074, 2021 JUN 30

Other Recalls from Pfizer Inc.

Recall # Classification Product Date
D-0545-2025 Class II Bicillin L-A (penicillin G benzathine injectabl... Jul 10, 2025
D-0544-2025 Class II Bicillin L-A (penicllin G benzathine injectable... Jul 10, 2025
D-0489-2025 Class II DOBUTamine Injection, USP, 250 mg/20 mL (12.5 m... May 28, 2025
D-0564-2024 Class II Buprenorphine Hydrochloride Injection, 0.3 mg b... May 20, 2024
D-0565-2024 Class II Labetalol Hydrochloride Injection, USP, 20 mg/4... May 20, 2024

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.